Join this Featured Workgroup!
Elite Investors

This group is for elite investors and traders that are dedicated to participating in an active community that wants to learn from each other, share their research, and work together to do deep analysis of securities. The moderator of this group taught securities analysis at UCLA and is dedicated to helping other investors improve their abilities.

In this private group, membership is restricted and regular contributions are required. Any member not contributing on a regular basis will be removed to make room for a new member.

In your application messsage, please share your background and what you can contribute to the group.



Company Overview and News

9
26 'Safer' Dividend 10%+ Yield Stocks Sparkle For July

2018-07-06 seekingalpha
26 of 82 stocks sporting 10%+ yields were tagged as "safer" for dividends because they showed positive 1-year returns and free cash flow yields greater than their dividend yields on 7/3/18.
AIY TCRX AINV SXCP CRIUF AIB ORC TCRD TCRZ TEO VEDL TSLF KIROY KUMBF GMLP CAPL EARN SUN VEDL SNMP

11
Just 16 'Safer' Dividend 9%+ Yield Wall St. Stars Blossom For Summer

2018-06-24 seekingalpha
16 of 75 Wall St. favorites sporting 9%+ yields were tagged as "safer" for dividends because they showed positive one-year returns and free cash flow yields greater than their dividend yields 6/20/18.
AIY TCRX AINV HMLP SXCP DX AIB ORC TCRD TCRZ TSLF GMLP CAPL SUN DX.PRB DX.PRA HMLP.PRA SNMP

126
Adient PLC: Is It Too Late To Sell?

2018-06-18 seekingalpha
CEO cashed out his shares and resigned, and Moody's downgraded its rating outlook in response to Cash Flow and EBITDA guidance cut.
WFCNP SXCP MS.PRE WFC.PRL MS.PRF WFC.PRJ MS.PRG MS.PRA SXC WFC.PRT WFC.PRR WFC.PRQ WFC.PRP WFC.PRO GM.WS.A WFC.PRN GM.WS.B SUN GM.WS.C WFC.PRY MS GM WFC.PRX WFC.PRW WFC.PRV WFC WFC.WS ADNT MS.PRI MS.PRK BA GM.WSB

47
41 'Safer' Basic Materials Top Yielding Dividends For June

2018-06-14 seekingalpha
41 of 87 Basic Materials top yield stocks were tagged "safer" for dividends because they showed positive annual returns and free cash flow yields greater than their dividend yields.
RIO BLT RIO SXCP PKX 0336 KIROY RTPPF HUABF KUMBF RTNTF SWM BHPBF WLK SOUHY OCIP OSB VEDL BHP RIO BBL BHP BHPLF VEDL HUIHY

10
27 'Safer' Dividend 10%+Yield Stocks Grow In June

2018-06-05 seekingalpha
27 of 74 stocks sporting 10%+yields were tagged as "safer" for dividends because they showed positive one-year returns and free-cash-flow yields greater than their dividend yields as of 6/1/18.
AIY TCRX AINV SXCP DX AIB ORC TCRD TCRZ VEDL TSLF KIROY KUMBF GMLP CAPL SUN DX.PRB DX.PRA VEDL SNMP

24
Top MLP Losses in the Week Ending May 18

2018-05-22 marketrealist
Teekay Offshore Partners (TOO), an MLP mainly involved in the marine transportation of crude oil, NGLs, and refined products, was the top MLP loss in the week ending May 18. Teekay Offshore Partners fell 4.2%. Last week, the decline could be due to Teekay Offshore Partners’ weak first-quarter earnings. The partnership reported income from vessel operations of $19.5 million in the first quarter—compared to $60.
TOO GLOP.PRA SXCP GLOP.PRB GLOP CNXM BPL SEP CCLP TOO.PRE PBFX CAPL CNNX EEP TOO.PRB TOO.PRA

27
MLPs: Buy After Distribution Cuts Or Run Away?

2018-05-17 seekingalpha
Many income investors sell on cuts to dividends and distributions. Other investors take a vulture-like approach and buy. Who is right?
UNIT SXCP BPL NS.PRC NS.PRB UAN GNE WPZ GNE NS EEP GEL NS.PRA

64
24 'Safer' Basic Materials 'WallStar' Dividends For May

2018-05-13 seekingalpha
24 of 45 Basic Materials top yield 'WallStar' stocks were tagged "safer" for dividends because they showed positive annual-returns, and free cash-flow yields greater than their dividend yields 5/10/18.
OLN APD SXCP WLK CBT LYB RGORF GOLD RRS DWDP GOLD ACIIQ MRI.U ACI MERC LALWF ARCH

30
45 Basic Materials Wall St. Dividend Stars For May

2018-05-12 seekingalpha
Coal, Agribusiness, Chemicals, & Fibers topped May's Basic Materials sector 'WallStars' for gains, calculated by broker 1yr targets & 5/10/18.
ARLP CCR TGLS CINR SXCP WLK GPRE EVA HCLP

9
Top MLP Losses in the Week Ending April 27

2018-05-01 marketrealist
SunCoke Energy Partners (SXCP), an MLP involved in coke manufacturing and logistics, was the top MLP loss in the week ending April 27. The partnership had weak earnings in 1Q18. The partnership posted an adjusted EBITDA of $49.5 million during 1Q18—compared to $51.7 million in 1Q17 The YoY decline was mainly driven by planned outage and maintenance costs in the partnership’s Domestic Coke segment. However, the partnership reaffirmed its 2018 adjusted EBITDA guidance of $215 million–$225 million.
LGCYP LGCYO TLP GLOP.PRA SXCP GLOP.PRB GLOP TEP TEGP UAN EQM CAPL LGCY NRP

17
Gains Carryforward Into Earnings

2018-04-30 seekingalpha
After back-to-back 3% weekly gains, MLPs traded up slightly for a third straight week, slightly ahead of the S&P 500. As discussed last week, MLPs haven't had 3% gains 3 weeks in a row ever, so this week's pause is not a surprise, especially with flat broad market and oil prices.
TRP SXCP IPPLF IPL AR

1
SunCoke Energy Partners 2018 Q1 - Results - Earnings Call Slides

2018-04-26 seekingalpha
The following slide deck was published by SunCoke Energy Partners in conjunction with their 2018 Q1 earnings call.
SXCP

1
SunCoke Energy Partners' (SXCP) CEO Mike Rippey on Q1 2018 Results - Earnings Call Transcript

2018-04-26 seekingalpha
Good morning and good afternoon. My name is Draclin, and I will be your conference operator today. At this time, I would like to welcome everyone to the SunCoke Energy Partners’ Q1 2018 Earnings Call. All lines have been placed on mute to prevent any background noise. After the speaker’s remarks, there will be a question-and-answer session. [Operator Instructions] Thank you.
SXCP

Related Articles

KTOV: Kitov Pharamceuticals Holdings Analysis and Research Report

2018-07-17 - Asif

History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...

ATHX: Athersys Analysis and Research Report

2018-07-17 - Asif

Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...

CYTX: Cytori Therapeutics Analysis and Research Report

2018-07-16 - Asif

General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...

CUSIP: 86722Y101